ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,445.60
2.16%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,175.50
6.84%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. SpringWorks Therapeutics Inc (SWTX)

  7. SpringWorks Therapeutics Inc (SWTX) 뉴스

SWTX SpringWorks Therapeutics Inc

45.11
1.76 (4.06%)
시간외 거래
최종 업데이트: 07:00:03
15분 지연
기업명 주식 심볼 시장 주식 타입
SpringWorks Therapeutics Inc SWTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
1.76 4.06% 45.11 07:00:03
개장가 저가 고가 종가 전일 종가
44.09 42.12 45.13 45.11 43.35
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202419:30GLOBESpringWorks Therapeutics Reports First Quarter 2024..
25/04/202402:31GLOBESpringWorks Therapeutics Announces Abstracts Accepted for..
18/04/202420:00GLOBESpringWorks Therapeutics to Report First Quarter 2024..
04/03/202420:30GLOBESpringWorks Therapeutics Initiates Rolling Submission of New..
02/03/202407:16EDGAR2Form 144 - Report of proposed sale of securities
29/02/202422:30GLOBESpringWorks Therapeutics Announces European Medicines Agency..
27/02/202422:28EDGAR2Form 8-K - Current report
27/02/202422:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/02/202421:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/02/202420:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202420:44EDGAR2Form 8-K - Current report
27/02/202420:30GLOBESpringWorks Therapeutics Reports Fourth Quarter and Full..
22/02/202421:00GLOBESpringWorks Therapeutics to Present at Upcoming Investor..
21/02/202408:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202403:09EDGAR2Form 144 - Report of proposed sale of securities
14/02/202422:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202411:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:38EDGAR2Form 144 - Report of proposed sale of securities
03/02/202406:01EDGAR2Form 8-K - Current report
31/01/202421:00GLOBESpringWorks Therapeutics to Participate in the Guggenheim..
09/01/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202411:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202411:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202411:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202411:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202420:30GLOBESpringWorks Therapeutics Highlights 2023 Accomplishments and..
21/12/202321:00GLOBESpringWorks Therapeutics to Present at the 42nd Annual J.P...
09/12/202306:05GLOBESpringWorks Therapeutics Announces Closing of Upsized Public..
07/12/202306:10EDGAR2Form 8-K - Current report
07/12/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202314:32GLOBESpringWorks Therapeutics Announces Pricing of Upsized Public..
05/12/202306:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202306:13GLOBESpringWorks Therapeutics Announces Proposed Public Offering..
29/11/202321:00GLOBESpringWorks Therapeutics to Participate in the 6th Annual..
28/11/202323:00EDGAR2Form 8-K - Current report
28/11/202321:53DJNSpringWorks Shares Rise on FDA Approval for Tumor Treatment
28/11/202308:46DJNSpringWorks Gets FDA Approval for Desmoid Tumor Treatment
28/11/202308:04GLOBESpringWorks Therapeutics Announces FDA Approval of OGSIVEO™..
17/11/202321:00EDGAR2Form 8-K - Current report
16/11/202320:30GLOBESpringWorks Therapeutics Announces Positive Topline Results..
03/11/202310:02EDGAR2Form 144 - Report of proposed sale of securities
02/11/202320:54EDGAR2Form S-3ASR - Automatic shelf registration statement of..
02/11/202319:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202319:35EDGAR2Form 8-K - Current report
02/11/202319:30GLOBESpringWorks Therapeutics Reports Third Quarter 2023..
01/11/202319:30GLOBESpringWorks Therapeutics Announces Presentation of..
05/10/202305:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/09/202305:37EDGAR2Form 3 - Initial statement of beneficial ownership of..

최근 히스토리

NASDAQ
SWTX
SpringWorks Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유